146 related articles for article (PubMed ID: 11240265)
21. Investigation of Werner protein as an early DNA damage response in actinic keratosis, Bowen disease and squamous cell carcinoma.
Cha HJ; Lee DB; Jung HN; Choi YS; Suh HS
Clin Exp Dermatol; 2015 Jul; 40(5):564-9. PubMed ID: 25545408
[TBL] [Abstract][Full Text] [Related]
22. Comparison of oxidative stress on DNA, protein and lipids in patients with actinic keratosis, Bowen's disease and squamous cell carcinoma.
Yoshifuku A; Fujii K; Kanekura T
J Dermatol; 2018 Nov; 45(11):1319-1323. PubMed ID: 30222205
[TBL] [Abstract][Full Text] [Related]
23. Bivalent binding and signaling characteristics of Leridistim, a novel chimeric dual agonist of interleukin-3 and granulocyte colony-stimulating factor receptors.
Monahan JB; Hood WF; Welply JK; Shieh JJ; Polazzi JO; Li X
Exp Hematol; 2001 Apr; 29(4):416-24. PubMed ID: 11301181
[TBL] [Abstract][Full Text] [Related]
24. The granulocyte colony-stimulating factor receptor supports erythroid differentiation in the absence of the erythropoietin receptor or Stat5.
Millot GA; Svinarchuk F; Lacout C; Vainchenker W; Dumenil D
Br J Haematol; 2001 Feb; 112(2):449-58. PubMed ID: 11167846
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical staining of palisading basal cells in Bowen's disease and basal involvement in actinic keratosis: contrasting staining patterns suggest different cells of origin.
Saglam O; Salama M; Meier F; Chaffins M; Ma C; Ormsby A; Lee M
Am J Dermatopathol; 2008 Apr; 30(2):123-6. PubMed ID: 18360114
[TBL] [Abstract][Full Text] [Related]
26. Expression of granulocyte colony stimulating factor receptor in human colorectal cancer.
Yang X; Liu F; Xu Z; Chen C; Wu X; Li G; Li J
Postgrad Med J; 2005 May; 81(955):333-7. PubMed ID: 15879049
[TBL] [Abstract][Full Text] [Related]
27. Expression of L-type amino acid transporter 1 in various skin lesions.
Hirano K; Uno K; Kuwabara H; Kojima K; Ohno S; Sakurai H; Kamma H; Kurata A
Pathol Res Pract; 2014 Oct; 210(10):634-9. PubMed ID: 24939142
[TBL] [Abstract][Full Text] [Related]
28. CCR10 and CCL27 are overexpressed in cutaneous squamous cell carcinoma.
Kai H; Kadono T; Kakinuma T; Tomita M; Ohmatsu H; Asano Y; Tada Y; Sugaya M; Sato S
Pathol Res Pract; 2011 Jan; 207(1):43-8. PubMed ID: 21144674
[TBL] [Abstract][Full Text] [Related]
29. p16INK4a expression in actinic keratosis and Bowen's disease.
Salama ME; Mahmood MN; Qureshi HS; Ma C; Zarbo RJ; Ormsby AH
Br J Dermatol; 2003 Nov; 149(5):1006-12. PubMed ID: 14632806
[TBL] [Abstract][Full Text] [Related]
30. [Expression of E-cadherin and beta-catenin in Bowen's disease and squamous cell carcinoma].
Li ZX; Peng ZH; Ji FP; Yuan JY; Pan M; Liu Y; Wang Q
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1245-7. PubMed ID: 16939929
[TBL] [Abstract][Full Text] [Related]
31. Granulocyte-colony-stimulating factor enhances invasive potential of human head-and-neck-carcinoma cell lines.
Noda I; Fujieda S; Ohtsubo T; Tsuzuki H; Tanaka N; Sunaga H; Saito H
Int J Cancer; 1999 Jan; 80(1):78-84. PubMed ID: 9935235
[TBL] [Abstract][Full Text] [Related]
32. Growth and differentiation signals mediated by different regions in the cytoplasmic domain of granulocyte colony-stimulating factor receptor.
Fukunaga R; Ishizaka-Ikeda E; Nagata S
Cell; 1993 Sep; 74(6):1079-87. PubMed ID: 7691413
[TBL] [Abstract][Full Text] [Related]
33. Expression of cell-cycle proteins p53, p21 (WAF-1), PCNA and Ki-67 in benign, premalignant and malignant skin lesions with implicated HPV involvement.
Lu S; Tiekso J; Hietanen S; Syrjänen K; Havu VK; Syrjänen S
Acta Derm Venereol; 1999 Jul; 79(4):268-73. PubMed ID: 10429981
[TBL] [Abstract][Full Text] [Related]
34. Expression of bcl-2, p53 and Ki-67 in arsenical skin cancers.
Chang CH; Tsai RK; Chen GS; Yu HS; Chai CY
J Cutan Pathol; 1998 Oct; 25(9):457-62. PubMed ID: 9821074
[TBL] [Abstract][Full Text] [Related]
35. Participation of granulocyte colony-stimulating factor in the growth regulation of leukemia cells from Philadelphia chromosome-positive acute leukemia and blast crisis of chronic myeloid leukemia.
Inukai T; Sugita K; Mitsui K; Iijima K; Goi K; Tezuka T; Kojika S; Kagami K; Mori T; Kinoshita A; Suzuki T; Okazaki-Koyama T; Nakazawa S
Leukemia; 2000 Aug; 14(8):1386-95. PubMed ID: 10942233
[TBL] [Abstract][Full Text] [Related]
36. Granulocyte-Colony Stimulating Factor Receptor, Tissue Factor, and VEGF-R Bound VEGF in Human Breast Cancer In Loco.
Wojtukiewicz MZ; Sierko E; Skalij P; Kamińska M; Zimnoch L; Brekken RA; Thorpe PE
Adv Clin Exp Med; 2016; 25(3):505-11. PubMed ID: 27629739
[TBL] [Abstract][Full Text] [Related]
37. Expression of p300 and p300/CBP associated factor (PCAF) in actinic keratosis and squamous cell carcinoma of the skin.
Bosic MM; Brasanac DC; Stojkovic-Filipovic JM; Zaletel IV; Gardner JM; Cirovic SL
Exp Mol Pathol; 2016 Jun; 100(3):378-85. PubMed ID: 27019369
[TBL] [Abstract][Full Text] [Related]
38. Expression and functional analysis of granulocyte colony-stimulating factor receptors on CD34++ cells in patients with myelodysplastic syndrome (MDS) and MDS-acute myeloid leukaemia.
Sultana TA; Harada H; Ito K; Tanaka H; Kyo T; Kimura A
Br J Haematol; 2003 Apr; 121(1):63-75. PubMed ID: 12670333
[TBL] [Abstract][Full Text] [Related]
39. Assessment of cell proliferation in benign, premalignant and malignant skin lesions.
Bordbar A; Dias D; Cabral A; Beck S; Boon ME
Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):229-35. PubMed ID: 17525640
[TBL] [Abstract][Full Text] [Related]
40. Expression of granulocyte-colony-stimulating factor and its receptor in human Ewing sarcoma cells and patient tumor specimens: potential consequences of granulocyte-colony-stimulating factor administration.
Morales-Arias J; Meyers PA; Bolontrade MF; Rodriguez N; Zhou Z; Reddy K; Chou AJ; Koshkina NV; Kleinerman ES
Cancer; 2007 Oct; 110(7):1568-77. PubMed ID: 17694551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
